Home » Topics » Disease categories and therapies » Neurology/psychiatric

Neurology/psychiatric
RSS

Optically pure trimebutine metabolite useful for chronic pain

March 9, 1999

Esteve patents novel compounds with multiple effects on the CNS

March 9, 1999

Anesta begins launch of novel analgesic

March 9, 1999

FDA approves controlled-release form of popular antidepressant

March 8, 1999

Na+/Ca2+ exchange inhibitor provides effective neuroprotection in vitro

March 8, 1999

Muscarinic receptor modulators for psychotic disorders patented by Lilly

March 8, 1999

Uncompetitive NMDA antagonists show improved efficacy in Parkinson's disease models

March 8, 1999

GenoPlex licenses rights to AD discoveries from MGH

March 5, 1999

Single-isomer version of epilepsy Rx developed at ABS

March 5, 1999

Lilly delays phase III clinical trials of migraine compound

March 5, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 31, 2026.
AIDS 2026: New targets for metabolic dysfunction despite ART
BioWorld
Although antiretroviral therapy (ART) can suppress HIV to undetectable levels, a growing body of evidence suggests that the virus leaves a lasting biological...
Tuojie Biotech (Shanghai) synthesizes new SARM1 inhibitors
BioWorld Science
Tuojie Biotech (Shanghai) Co. Ltd. has prepared and tested NAD(+) hydrolase SARM1 (SAMD2; MyD88-5) inhibitors found to be potentially useful for the treatment of...
Jingxin discloses new muscarinic and sigma receptor agonists
BioWorld Science
Shanghai Jingxin Biopharmaceutical Co. Ltd. and Zhejiang Jingxin Pharmaceutical Co. Ltd. have synthesized new muscarinic acetylcholine receptor and sigma receptor...
Death in Chinese gene-editing trial exposes ethical fault lines
BioWorld
The death of a 6-year-old girl after receiving an experimental brain-directed gene-editing therapy at the Xinhua Hospital in Shanghai has reopened debate over how...